303 related articles for article (PubMed ID: 12865275)
1. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
Ahmed N; Corey M; Forstner G; Zielenski J; Tsui LC; Ellis L; Tullis E; Durie P
Gut; 2003 Aug; 52(8):1159-64. PubMed ID: 12865275
[TBL] [Abstract][Full Text] [Related]
2. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency.
Walkowiak J; Herzig KH; Witt M; Pogorzelski A; Piotrowski R; Barra E; Sobczynska-Tomaszewska A; Trawinska-Bartnicka M; Strzykala K; Cichy W; Sands D; Rutkiewicz E; Krawczynski M
Eur J Clin Invest; 2001 Sep; 31(9):796-801. PubMed ID: 11589722
[TBL] [Abstract][Full Text] [Related]
3. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
4. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
5. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
6. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations.
Walkowiak J; Sands D; Nowakowska A; Piotrowski R; Zybert K; Herzig KH; Milanowski A
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):199-201. PubMed ID: 15699697
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
8. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
9. Genetic determination of exocrine pancreatic function in cystic fibrosis.
Kristidis P; Bozon D; Corey M; Markiewicz D; Rommens J; Tsui LC; Durie P
Am J Hum Genet; 1992 Jun; 50(6):1178-84. PubMed ID: 1376016
[TBL] [Abstract][Full Text] [Related]
10. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
Ooi CY; Dorfman R; Cipolli M; Gonska T; Castellani C; Keenan K; Freedman SD; Zielenski J; Berthiaume Y; Corey M; Schibli S; Tullis E; Durie PR
Gastroenterology; 2011 Jan; 140(1):153-61. PubMed ID: 20923678
[TBL] [Abstract][Full Text] [Related]
11. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
12. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
13. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.
McKone EF; Emerson SS; Edwards KL; Aitken ML
Lancet; 2003 May; 361(9370):1671-6. PubMed ID: 12767731
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of CFTR gene in 70 Iranian cystic fibrosis patients.
Alibakhshi R; Zamani M
Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):3-8. PubMed ID: 17242497
[TBL] [Abstract][Full Text] [Related]
15. A cystic fibrosis patient homozygous for 621 + 1G-->T mutation has a severe pulmonary disease, mild pancreatic insufficiency and a gastro-esophageal reflux.
Witt M; Pogorzelski A; Zebrak J; Rutkiewicz E
Clin Genet; 1996 Sep; 50(3):149-51. PubMed ID: 8946114
[TBL] [Abstract][Full Text] [Related]
16. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations.
Koch C; Cuppens H; Rainisio M; Madessani U; Harms H; Hodson M; Mastella G; Navarro J; Strandvik B; McKenzie S;
Pediatr Pulmonol; 2001 Jan; 31(1):1-12. PubMed ID: 11180668
[TBL] [Abstract][Full Text] [Related]
17. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
Geborek A; Hjelte L
J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients.
Hubert D; Bienvenu T; Desmazes-Dufeu N; Fajac I; Lacronique J; Matran R; Kaplan JC; Dusser DJ
Eur Respir J; 1996 Nov; 9(11):2207-14. PubMed ID: 8947061
[TBL] [Abstract][Full Text] [Related]
19. Thirteen cystic fibrosis patients, 12 compound heterozygous and one homozygous for the missense mutation G85E: a pancreatic sufficiency/insufficiency mutation with variable clinical presentation.
Vazquez C; Antiñolo G; Casals T; Dapena J; Elorz J; Seculi JL; Sirvent J; Cabanas R; Soler C; Estivill X
J Med Genet; 1996 Oct; 33(10):820-2. PubMed ID: 8933333
[TBL] [Abstract][Full Text] [Related]
20. Exocrine pancreatic function in cystic fibrosis.
Guy-Crotte O; Carrère J; Figarella C
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):755-9. PubMed ID: 8864671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
